Growth Metrics

Globus Medical (GMED) Debt to Equity (2024)

Globus Medical posted quarterly Debt to Equity of $0.11 for Q4 2024, down 1.2% on a QoQ basis from $0.11 in Q3 2024.

Globus Medical (GMED) has 1 years of Debt to Equity data on file, last reported at $0.11 in Q4 2024.

  • For the quarter ending Q4 2024, Debt to Equity changed N/A year-over-year to $0.11; the trailing twelve-month figure through Dec 2024 stood at $0.11 (changed N/A YoY), and the FY2024 full-year result was $0.11, changed N/A from the prior year.
  • Debt to Equity for Q4 2024 stood at $0.11, down from $0.11 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.11 in Q2 2024 and bottomed at $0.11 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 0.11
Sep 30, 2024 0.11
Jun 30, 2024 0.11
Mar 31, 2024 0.11